Search results
Dr. Allison is a Nobel laureate and a pioneer of immunotherapy for cancer. He is the chair of the Department of Immunology, the director of the Parker Institute for Cancer Immunotherapy, and the executive director of the Immunotherapy Platform at MD Anderson Cancer Center.
James Patrick Allison (born August 7, 1948) is an American immunologist and Nobel laureate who holds the position of professor and chair of immunology and executive director of immunotherapy platform at the MD Anderson Cancer Center at the University of Texas.
James Allison is an American immunologist who discovered how to inhibit negative immune regulation and treat cancer. He shared the Nobel Prize with Tasuku Honjo for their groundbreaking work on cancer therapy.
The Nobel Prize in Physiology or Medicine 2018 was awarded jointly to James P. Allison and Tasuku Honjo "for their discovery of cancer therapy by inhibition of negative immune regulation"
May 9, 2024 · James P. Allison, American immunologist who contributed to the discovery of mechanisms underlying T-cell activation and who was a pioneer in the development of immune checkpoint therapy for cancer. Allison was a corecipient of the 2018 Nobel Prize for Physiology or Medicine.
- Kara Rogers
Oct 1, 2018 · James P. Allison studied a known protein that functions as a brake on the immune system. He realized the potential of releasing the brake and thereby unleashing our immune cells to attack tumors. He then developed this concept into a brand new approach for treating patients.
Apr 18, 2014 · Learn about the Nobel Prize-winning immunologist who discovered the T cell brakes and pioneered cancer immunotherapy. Find out how he studies T cells, identifies targets, and treats patients with checkpoint blockade antibodies.
